Since SOCS6 gene was reported downregulated in pancreatic cancer9, we utilized pancreatic cancer cell line PANC1 and BXPC3 to examine the potential impact of SOCS6 to mTORC2-AKT pathway. This evidence concerns the gene SOCS6 and familial pancreatic carcinoma.